Skip to content
Wenlo
Sign in
← Markets

Revolution Medicines, Inc.

Anthony Mancini (See Remarks) sells RVMD shares

4RVMDFiled Oct 28, 2026, 6:00 PM ET· Period Oct 26, 2026

AI-generated summary

Anthony Mancini, See Remarks, exercised 2,310 stock options for 2,310 shares of Common Stock at an average price of $33.62 for a value of $77,662.20. Anthony Mancini also sold 2,310 shares of Common Stock at an average price of $186.99 for a value of $431,946.90. Following these transactions, Anthony Mancini directly held 39,765 shares of Common Stock. These transactions were made under a Rule 10b5-1 trading plan adopted on June 11, 2026.

View original filing on SEC.gov (opens SEC EDGAR)

Key facts

Insider
Anthony Mancini · See Remarks

Rule 10b5-1 plan · adopted Jun 11, 2026

DateTransactionSharesPriceValueHeld afterOwnership
Oct 26, 2026M · exercise or conversion of a derivativeFootnotes F1+2,310$33.62$77,662.2042,075Direct
Oct 26, 2026S · open-market saleFootnotes F1, F2−2,310$186.99$431,946.9039,765Direct
Oct 26, 2026M · exercise or conversion of a derivativeStock Option (Right to Buy)Footnotes F1, F3−2,310$0.00$0.0091,315Direct
Footnotes
  1. F1 Transaction made pursuant to a 10b5-1 trading plan adopted by Anthony Mancini on June 11, 2026.
  2. F2 Includes 39,575 restricted stock units.
  3. F3 Twenty-five percent of the total shares subject to the option will vest on the first year anniversary measured from April 1, 2025 (the "Vesting Commencement Date") and one forty-eighth (1/48th) of the shares subject to the option will vest on each monthly anniversary of the Vesting Commencement Date thereafter, so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.

Remarks: Chief Global Commercialization Officer

More RVMD filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.